Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

EREctile Function Preservation for Prostate Cancer Radiation Therapy (ERECT); a Prospective Phase II Trial

NCT04861194 is registered in ClinicalTrials.gov with UMC Utrecht as lead sponsor.

NCT NCT04861194
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04861194 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
EREctile Function Preservation for Prostate Cancer Radiation Therapy (ERECT); a Prospective Phase II Trial
Lead sponsor
UMC Utrecht
Phase
Not applicable
Overall status
Recruiting
Start date
July 14, 2021
Completion date
August 10, 2027
Enrollment
70 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

erectile dysfunction following radiation therapy, prostate cancer